WAI CHUN BIOTEC (00660.HK): 2026 Annual Results May Be Delayed, Trading May Be Suspended

NewTimeSpace News: On 22 September 2026, Wai Chun Bio-Technology Limited (stock code: 00660) announced that, as the Company and its auditors require additional time to complete the audit, the Company will not be able to publish its annual results for the year ended 30 June 2026 (the 2026 annual results) on or before 30 September 2026. The announcement was made pursuant to Rules 13.09(2)(a) and 13.49(3) of the Listing Rules and the inside information provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Under Rule 13.49(1) of the Listing Rules, the Company is required to publish the 2026 annual results within three months after the end of its financial year, i.e. on or before 30 September 2026. The Company is working closely with its auditors and providing all necessary information and documents to complete the audit procedures as soon as possible, but further discussion with the auditors will be required to determine the expected publication date of the annual results, and a further announcement will be made in due course. The Board confirmed that the Company operates as usual and its business is not affected.

Under Rule 13.49(3) of the Listing Rules, if the Company fails to publish the 2026 annual results within the prescribed time, it must publish its results based on the financial results (to the extent available) that have not been agreed with the auditors. After due and careful consideration, the Board considers that it is not appropriate at this stage to publish unaudited management accounts, as such accounts may not accurately reflect the Group's financial performance and/or position and may mislead investors and shareholders.

Under Rule 13.50 of the Listing Rules, if an issuer fails to publish periodic financial information in accordance with the Listing Rules, the Stock Exchange will normally require the suspension of trading in the issuer's securities, and such suspension will normally remain in effect until the issuer publishes an announcement containing the required financial information. The Board will make further announcements in due course to inform shareholders of any updates regarding the publication of the 2026 annual results and any possible suspension of trading in the Company's shares.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.